Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (128) 128
index medicus (88) 88
pathology (74) 74
male (68) 68
female (63) 63
immunohistochemistry (57) 57
middle aged (56) 56
aged (52) 52
cancer (46) 46
oncology (43) 43
adult (39) 39
tumors (39) 39
article (32) 32
animals (28) 28
carcinoma (28) 28
expression (25) 25
aged, 80 and over (22) 22
kidney neoplasms - pathology (22) 22
metastasis (21) 21
adenocarcinoma (20) 20
biomarkers, tumor - metabolism (20) 20
microbiology (20) 20
biomarkers, tumor - analysis (19) 19
biochemistry (18) 18
gene expression regulation, neoplastic (18) 18
surgery (18) 18
beer (17) 17
chemistry (17) 17
compositions thereof (17) 17
culture media (17) 17
enzymology (17) 17
gene expression (17) 17
gene-expression (17) 17
metallurgy (17) 17
microorganisms or enzymes (17) 17
mutation or genetic engineering (17) 17
propagating, preserving or maintaining microorganisms (17) 17
spirits (17) 17
vinegar (17) 17
wine (17) 17
mice (16) 16
mutation (16) 16
research (16) 16
analysis (15) 15
renal cell carcinoma (15) 15
adenocarcinoma - pathology (14) 14
diagnosis (14) 14
gene expression profiling (14) 14
human necessities (14) 14
hygiene (14) 14
kidney neoplasms - genetics (14) 14
lung cancer (14) 14
medical or veterinary science (14) 14
oligonucleotide array sequence analysis (14) 14
organic chemistry (14) 14
peptides (14) 14
preparations for medical, dental, or toilet purposes (14) 14
cell line, tumor (13) 13
prostatic neoplasms - pathology (13) 13
biopsy (12) 12
carcinoma, renal cell - pathology (12) 12
kidney neoplasms - metabolism (12) 12
mutations (12) 12
prostate cancer (12) 12
adenocarcinoma - metabolism (11) 11
breast-cancer (11) 11
c-met (11) 11
cell biology (11) 11
diagnosis, differential (11) 11
phosphorylation (11) 11
prognosis (11) 11
signal transduction (11) 11
urinary bladder neoplasms - pathology (11) 11
carcinoma, renal cell (10) 10
carcinoma, renal cell - genetics (10) 10
carcinoma, renal cell - metabolism (10) 10
immunoenzyme techniques (10) 10
tissue array analysis (10) 10
abridged index medicus (9) 9
cells (9) 9
disease progression (9) 9
genetic aspects (9) 9
lung neoplasms - genetics (9) 9
lung neoplasms - metabolism (9) 9
lung neoplasms - pathology (9) 9
medicine, research & experimental (9) 9
neoplasm staging (9) 9
patients (9) 9
prostate (9) 9
reproducibility of results (9) 9
reverse transcriptase polymerase chain reaction (9) 9
treatment outcome (9) 9
apoptosis (8) 8
cell differentiation (8) 8
cell proliferation (8) 8
colorectal-cancer (8) 8
features (8) 8
growth (8) 8
neoplasms (8) 8
oncocytoma (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid angiomyolipoma: series of 4 primary tumors and 2 metastases
by Tretiakova, Maria S
Human Pathology, ISSN 0046-8177, 10/2018, Volume 80, pp. 65 - 75
Eosinophilic solid and cystic renal cell carcinoma (ESC-RCC) is a novel entity of rare tumors with rather unique morphology and immunohistochemical profile.... 
AML | Cystic | RCC | Mimicking | Solid | Epithelioid | Eosinophilic | PATHOLOGY | Neoplasm Recurrence, Local - pathology | Carcinoma, Renal Cell - pathology | Neoplasm Metastasis - pathology | Humans | Middle Aged | Adult | Female | Kidney Neoplasms - pathology | Male | Aged | Angiomyolipoma - pathology | Biomarkers, Tumor - genetics | Keratin | Medical colleges | Development and progression | Carcinoma, Renal cell | Metastasis | Analysis | Pathology | Antigens | Laboratories | Patients | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text The expression of FOXL2 in pancreatic, hepatobiliary, and renal tumors with ovarian-type stroma
by Westerhoff, Maria, MD and Tretiakova, Maria, MD, PhD and Hart, John, MD and Gwin, Katja, MD, PhD and Liu, Xiuli, MD, PhD and Zhou, Ming, MD, PhD and Yeh, Matthew M., MD, PhD and Antic, Tatjana, MD
Human Pathology, ISSN 0046-8177, 2014, Volume 45, Issue 5, pp. 1010 - 1014
Summary FOXL2 , a gene encoding a member of the fork-head-winged-helix family of transcription factors, is one of the earliest expressed genes during female... 
Pathology | Pancreatic mucinous cystic neoplasm | FOXL2 | Hepatobiliary cystadenoma | Ovarian-type stroma | Mixed epithelial and stromal tumor of the kidney | CELL TUMORS | RECEPTOR | PATHOLOGY | PREGNANCY | FEATURES | BREAST-CANCER | EPITHELIAL CYSTS | ANGIOMYOLIPOMA | ESTROGEN | DIFFERENTIATION | KIDNEY | Forkhead Transcription Factors - biosynthesis | Obesity - complications | Stromal Cells - pathology | Humans | Middle Aged | Stromal Cells - metabolism | Cystadenoma - physiopathology | Male | Bile Duct Neoplasms - physiopathology | Kidney Neoplasms - physiopathology | Liver Neoplasms - physiopathology | Aged, 80 and over | Receptors, Estrogen - biosynthesis | Adult | Female | Aged | Alcoholism - complications | Pancreatic Neoplasms - physiopathology | Forkhead Box Protein L2 | Receptors, Progesterone - biosynthesis | Immunohistochemistry | Progesterone | Alcoholism | Estrogen | Tumors | Women | Genes
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text 14. Comprehensive diagnostic and discovery platform for translocation renal cell carcinomas using AMP/RNA-seq
by Liu, Yajuan and Tretiakova, Maria
Cancer Genetics, ISSN 2210-7762, 04/2019, Volume 233-234, pp. S6 - S6
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text An Unusual Manifestation of Blastic Plasmacytoid Dendritic Cell Neoplasm as a Testicular Tumor
by Pak, Daniel M and Tretiakova, Maria S
Case Reports in Pathology, ISSN 2090-6781, 10/2019, Volume 2019, pp. 1 - 4
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a clinically aggressive hematologic malignancy arising from precursors of plasmacytoid dendritic cells... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression
by Hua, Sujun and Kallen, Caleb B and Dhar, Ruby and Baquero, Maria T and Mason, Christopher E and Russell, Beth A and Shah, Parantu K and Liu, Jiang and Khramtsov, Andrey and Tretiakova, Maria S and Krausz, Thomas N and Olopade, Olufunmilayo I and Rimm, David L and White, Kevin P
Molecular Systems Biology, ISSN 1744-4292, 2008, Volume 4, Issue 1, pp. 188 - n/a
We demonstrate an integrated approach to the study of a transcriptional regulatory cascade involved in the progression of breast cancer and we identify a... 
histone variant | estrogen | cancer | chromatin | breast | Breast | Chromatin | Histone variant | Estrogen | Cancer | EXPRESSION PATTERNS | MITOTIC CHECKPOINT GENES | PROTEIN | BIOCHEMISTRY & MOLECULAR BIOLOGY | TRANSCRIPTION | C-MYC | RECEPTOR | INTERACTION NETWORKS | CYCLE PROGRESSION | BINDING-SITES | MAMMARY EPITHELIAL-CELLS | Histones - chemistry | Epigenesis, Genetic | Humans | Lymphatic Metastasis | Proto-Oncogene Proteins c-myc - metabolism | Disease Progression | Breast Neoplasms - metabolism | RNA Interference | Models, Biological | Biomarkers, Tumor - metabolism | Estrogen Receptor alpha - metabolism | Estrogens - metabolism | Genome | Chromatin - chemistry | Cell proliferation | Transcription factors | Immunoprecipitation | Profiling | Estrogens | Menopause | Genomes | Mapping | Metastasis | Myc protein | Cancer therapies | Lymph nodes | Metastases | Histones | Tiling | Deoxyribonucleic acid--DNA | Hypothesis testing | Data analysis | Genomic analysis | Therapeutic applications | RNA-mediated interference | Breast cancer | Gene expression | Studies | DNA microarrays | Medical prognosis | Epigenetics | Biomarkers | Diagnostic systems | Gene mapping | Binding sites | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Morphologic Assessment of Male Urethral Stricture and Correlation With Clinical Parameters
by Thaker, Ameet and Tretiakova, Maria
American Journal of Clinical Pathology, ISSN 0002-9173, 10/2014, Volume 142, Issue suppl_1, pp. A207 - A207
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Neoadjuvant enzalutamide prior to prostatectomy
by Montgomery, Bruce and Tretiakova, Maria S and Joshua, Anthony M and Gleave, Martin E and Fleshner, Neil and Bubley, Glenn J and Mostaghel, Elahe A and Chi, Kim N and Lin, Daniel W and Sanda, Martin and Novotny, William and Wu, Kenneth and Kantoff, Philip W and Marck, Brett T and Plymate, Stephen and Balk, Steven P and Nelson, Peter S and Matsumoto, Alvin M and Lis, Rosina T and Kibel, Adam and Haas, Gabriel P and Krivoshik, Andrew and Hannah, Alison and Taplin, Mary-Ellen
Clinical Cancer Research, ISSN 1078-0432, 05/2017, Volume 23, Issue 9, pp. 2169 - 2176
Purpose: Prostate cancer is dependent on androgen receptor (AR) activation. Optimal AR antagonism may effectively cytoreduce local disease and suppress or... 
THERAPY | ANTIANDROGEN | ONCOLOGY | RESISTANCE | PHASE-II | RADICAL PROSTATECTOMY | INCREASED SURVIVAL | CANCER | CHEMOTHERAPY | PROGRESSION | ABIRATERONE | Neoplasm, Residual - pathology | Phenylthiohydantoin - adverse effects | Prostatic Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prostatic Neoplasms - surgery | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Combined Modality Therapy | Neoplasm, Residual - blood | Phenylthiohydantoin - analogs & derivatives | Prostate-Specific Antigen - blood | Phenylthiohydantoin - administration & dosage | Receptors, Androgen - genetics | Leuprolide - administration & dosage | Neoadjuvant Therapy - adverse effects | Prostatic Neoplasms - blood | Prostatectomy | Aged | Neoplasm, Residual - chemically induced | Dutasteride - administration & dosage | Prostatic Neoplasms - drug therapy | Therapy | Risk groups | Health risks | Minimal residual disease | Patients | Anticancer properties | Testosterone | Signaling | Dihydrotestosterone | Androgens | Flutamide | Experimental design | Luteinizing hormone | Luteinizing hormone-releasing hormone | Antitumor activity | Prostate cancer | Prostate | Cancer | dutasteride | neoadjuvant | NEW MOLECULAR TARGETS | THERAPEUTICS: Cellular responses to anticancer drugs | CL01 PHASE I – III CLINICAL TRIALS: Phase I–III Trials_Genitourinary cancers: prostate | ET02 MECHANISMS OF DRUG ACTION | enzalutamide
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
by Livasy, Chad A and Karaca, Gamze and Nanda, Rita and Tretiakova, Maria S and Olopade, Olufunmilayo I and Moore, Dominic T and Perou, Charles M
Modern Pathology, ISSN 0893-3952, 02/2006, Volume 19, Issue 2, pp. 264 - 271
Microarray profiling of invasive breast carcinomas has identified five distinct subtypes of tumors ( luminal A, luminal B, normal breast-like, HER2... 
Basal | Breast carcinoma | HER2 | Gene expression profiling | Luminal | Microarrays | CANCER PATIENTS | DUCTAL CARCINOMAS | GENE-EXPRESSION PATTERNS | PATHOLOGY | basal | luminal | CENTRAL ACELLULAR ZONES | microarrays | COEXPRESSION | MOLECULAR PORTRAITS | VIMENTIN | breast carcinoma | DIFFERENTIATION | gene expression profiling | MORPHOLOGY | MAMMARY EPITHELIAL-CELLS | Immunohistochemistry | Oligonucleotide Array Sequence Analysis | Receptor, ErbB-2 - genetics | Humans | Trans-Activators - analysis | Gene Expression Profiling | Receptors, Estrogen - analysis | Breast - metabolism | Breast Neoplasms - metabolism | Keratins - analysis | Phosphoproteins - analysis | Actins - analysis | Female | Breast - pathology | Genes, Tumor Suppressor | DNA-Binding Proteins | Breast Neoplasms - classification | Receptors, Estrogen - genetics | Neoplasm Invasiveness | Neprilysin - analysis | Receptor, Epidermal Growth Factor - analysis | Muscle, Smooth - chemistry | Vimentin - analysis | Breast - chemistry | Phenotype | Breast Neoplasms - genetics | Keratin-6 | Transcription Factors | Keratin-5 | Receptor, ErbB-2 - analysis | Tumor Suppressor Proteins
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum
by Tretiakova, Maria and Mehta, Vikas and Kocherginsky, Masha and Minor, Agata and Shen, Steven S and Sirintrapun, Sahussapont Joseph and Yao, Jorge L and Alvarado-Cabrero, Isabel and Antic, Tatjana and Eggener, Scott E and Picken, Maria M and Paner, Gladell P
Virchows Archiv, ISSN 0945-6317, 7/2018, Volume 473, Issue 1, pp. 85 - 93
Multilocular cystic renal cell carcinoma has been recently excluded from clear cell renal cell carcinoma (CCRCC) category and re-designated as multilocular... 
Neoplasm | Pathology | Clear cell | Cystic | Carcinoma | Medicine & Public Health | Renal | Multilocular | SERIES | FOCUS | ADULTS | CHROMOSOME 3P | PATHOLOGY | TUMORS | PATHOBIOLOGICAL ASPECTS | ENTITIES | VHL | KIDNEY | Predictive Value of Tests | Kidney Neoplasms - genetics | United States | Humans | Middle Aged | Carcinoma, Renal Cell - genetics | Male | Neoplasms, Cystic, Mucinous, and Serous - secondary | Neoplasms, Cystic, Mucinous, and Serous - genetics | Neoplasm Grading | Time Factors | Aged, 80 and over | Adult | Female | Kidney Neoplasms - therapy | Risk Assessment | Risk Factors | In Situ Hybridization, Fluorescence | Kidney Neoplasms - mortality | Disease Progression | Carcinoma, Renal Cell - mortality | Neoplasms, Cystic, Mucinous, and Serous - therapy | Carcinoma, Renal Cell - secondary | Ploidies | Carcinoma, Renal Cell - therapy | Kidney Neoplasms - pathology | Mexico | Aged | Neoplasm Staging | Neoplasms, Cystic, Mucinous, and Serous - mortality | Medical colleges | Development and progression | Carcinoma, Renal cell | Metastasis | Analysis | Statistical analysis | Fatalities | Patients | Monosomy | Clear cell-type renal cell carcinoma | Metastases | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics
by Mantilla, Jose G and Antic, Tatjana and Tretiakova, Maria
Human Pathology, ISSN 0046-8177, 08/2017, Volume 66, pp. 152 - 158
Clear cell papillary renal cell carcinoma (CCPRCC) is a low-grade, indolent neoplasm with no reported cases of death from disease or metastasis. These lesions... 
Immunohistochemistry | Renal cell carcinoma | Clear cell papillary renal cell carcinoma | Tissue microarray | GATA3 | Genitourinary pathology | Renal neoplasms | DISTINCT | TUMOR | PATHOLOGY | KIDNEYS | ENTITY | NEOPLASIA | EMPHASIS | DISEASE | SPECTRUM | Predictive Value of Tests | Diagnosis, Differential | Reproducibility of Results | Biomarkers, Tumor - analysis | Carcinoma, Renal Cell - pathology | Tissue Array Analysis | Carcinoma, Renal Cell - chemistry | Humans | Middle Aged | Male | Kidney Neoplasms - chemistry | Biopsy | Carcinoma, Renal Cell - therapy | Adult | Female | Kidney Neoplasms - pathology | Aged | GATA3 Transcription Factor - analysis | Retrospective Studies | Keratin-7 - analysis | Kidney Neoplasms - therapy | Keratin | Metastasis | Cancer | Pathology | Histopathology | Laboratories | Cloning | Kidney diseases | Polymers | Patients | Tumors | Stains & staining
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression
by Lawless, Margaret and Gulati, Roman and Tretiakova, Maria
Histopathology, ISSN 0309-0167, 09/2017, Volume 71, Issue 3, pp. 406 - 414
Aims Pathological stage pT1 bladder cancers constitute a clinically heterogeneous group. However, current staging guidelines for superficially invasive cancers... 
papillary urothelial carcinoma | bladder | stalk invasion | CRITERIA | URINARY-BLADDER | UROTHELIAL CARCINOMA | PITFALLS | TUMOR | PATHOLOGY | CELL BIOLOGY | LAMINA PROPRIA INVASION | PROGNOSTIC-SIGNIFICANCE | DEPTH | Carcinoma, Transitional Cell - mortality | Urinary Bladder Neoplasms - mortality | Prognosis | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Carcinoma, Papillary - pathology | Disease Progression | Neoplasm Staging - methods | Carcinoma, Papillary - mortality | Disease-Free Survival | Carcinoma, Transitional Cell - pathology | Neoplasm Invasiveness - pathology | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Aged | Medicine, Experimental | Medical research | Development and progression | Bladder cancer | Rank tests | Urinary bladder | Identification methods | Invasiveness | Bladder | Lamina propria | Risk | Urothelial carcinoma | Health risk assessment | Patients | Incidence | Tumors | Papillary urothelial carcinoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Concordance study of PD-L1 expression in primary and metastatic bladder carcinomas: Comparison of four commonly used antibodies and RNA expression
by Tretiakova, Maria and Fulton, Regan and Kocherginsky, Masha and Long, Thomas and Ussakli, Cigdem and Antic, Tatjana and Gown, Allen
Modern Pathology, ISSN 0893-3952, 04/2018, Volume 31, Issue 4, pp. 623 - 632
Therapy with anti-PD-L1 immune check-point inhibitors is approved for several cancers, including advanced urothelial carcinomas. PD-L1 prevalence estimates... 
CELL LUNG-CANCER | HETEROGENEITY | BIOMARKER | IMMUNOTHERAPY | UROTHELIAL CARCINOMA | PROGRAMMED DEATH LIGAND-1 | ATEZOLIZUMAB | PATHOLOGY | ASSOCIATION | CHEMOTHERAPY | IMMUNOHISTOCHEMISTRY | RNA - analysis | Biomarkers, Tumor - analysis | Humans | Middle Aged | Male | Antibodies, Monoclonal | Tissue Array Analysis - methods | Immunohistochemistry - methods | Carcinoma, Transitional Cell - pathology | B7-H1 Antigen - biosynthesis | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Immunoassay - methods | Adult | Female | Aged | B7-H1 Antigen - analysis | Immunoglobulins | Automation | Image processing | Tumor cells | Antibodies | Metastasis | Ribonucleic acid--RNA | Lymph nodes | Metastases | Immunotherapy | PD-L1 protein | Urothelial carcinoma | Tumors | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Chemokine expression in melanoma metastases associated with CD8 + T-CeII recruitment
by Harlin, Helena and Meng, Yuru and Peterson, Amy C and Zha, Yuanyuan and Tretiakova, Maria and Slingluff, Craig and McKee, Mark and Gajewski, Thomas F
Cancer Research, ISSN 0008-5472, 04/2009, Volume 69, Issue 7, pp. 3077 - 3085
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors
by Nguyen, Liem T and Tretiakova, Maria S and Silvis, Mark R and Lucas, Jared and Klezovitch, Olga and Coleman, Ilsa and Bolouri, Hamid and Kutyavin, Vassily I and Morrissey, Colm and True, Lawrence D and Nelson, Peter S and Vasioukhin, Valeri
Cancer Cell, ISSN 1535-6108, 06/2015, Volume 27, Issue 6, pp. 797 - 808
The significance of ERG in human prostate cancer is unclear because mouse prostate is resistant to ERG-mediated transformation. We determined that ERG... 
PROGENITOR CELLS | ANDROGEN RECEPTOR | GENE FUSIONS | ORGAN SIZE | PTEN LOSS | METASTASIS | ONCOLOGY | HIPPO PATHWAY | SIZE-CONTROL | CANCER PROGRESSION | MESENCHYMAL TRANSITION | CELL BIOLOGY | Transcriptional Regulator ERG | Oncogene Proteins - genetics | Prostatic Neoplasms - metabolism | Translocation, Genetic | Up-Regulation | Age Factors | Humans | Transcriptional Activation | Gene Expression Regulation, Neoplastic | Male | Phosphoproteins - antagonists & inhibitors | Phosphoproteins - metabolism | Prostatic Neoplasms - genetics | Adaptor Proteins, Signal Transducing - antagonists & inhibitors | Trans-Activators - genetics | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Signal Transduction | Oncogene Proteins - metabolism | Mice, Transgenic | Phosphoproteins - genetics | Porphyrins - pharmacology | Random Allocation | Transcription Factors - genetics | Transcription Factors - metabolism | Xenograft Model Antitumor Assays | Animals | Adaptor Proteins, Signal Transducing - genetics | Trans-Activators - metabolism | Mice | Adaptor Proteins, Signal Transducing - metabolism | Genetic aspects | Genetic transcription | Prostate cancer | Genomics | Stem cells | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text PAX8-Positive B-Cell Lymphoma in Adrenal Gland Masquerading as Metastatic Renal Cell Carcinoma
by Parakh, Rugvedita and Cheng, Lin and Tretiakova, Maria
International Journal of Surgical Pathology, ISSN 1066-8969, 12/2018, Volume 26, Issue 8, pp. 721 - 724
Extranodal lymphomas involve adrenal glands as a mass lesion in 3% to 5% of cases as identified by imaging studies. Definitive diagnosis of the neoplasm is... 
renal cell carcinoma | neoplasm | adrenal | PAX8 | lymphoma | SURGERY | PATHOLOGY | TUMORS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation
by Weber, Christopher R and Nalle, Sam C and Tretiakova, Maria and Rubin, David T and Turner, Jerrold R
Laboratory Investigation, ISSN 0023-6837, 10/2008, Volume 88, Issue 10, pp. 1110 - 1120
Patients with inflammatory bowel disease (IBD) are at increased risk of developing colorectal adenocarcinoma. The factors that result in IBD-associated... 
Inflammatory bowel disease | Tight junction | Dysplasia | Colon cancer | Claudin | Occludin | MEDICINE, RESEARCH & EXPERIMENTAL | DIFFERENTIAL EXPRESSION | CROHNS-DISEASE | colon cancer | SELF-LIMITED COLITIS | ULCERATIVE-COLITIS | NECROSIS-FACTOR-ALPHA | PATHOLOGY | claudin | inflammatory bowel disease | CHAIN KINASE EXPRESSION | dysplasia | EPITHELIAL BARRIER DYSFUNCTION | occludin | INTERFERON-GAMMA | COLORECTAL-CANCER | TIGHT JUNCTION PROTEINS | tight junction | Up-Regulation | Colitis, Ulcerative - metabolism | Humans | Middle Aged | Crohn Disease - metabolism | Male | Claudin-1 | Colitis, Ulcerative - immunology | Crohn Disease - immunology | beta Catenin - metabolism | Colonic Neoplasms - metabolism | Adenoma - metabolism | Claudins | Inflammation - metabolism | Aged, 80 and over | Female | Aged | Membrane Proteins - metabolism | Cohort Studies | Index Medicus | claudin-4 | claudin-2 | claudin-1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights